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Postnatal development of the mammary gland is determined by reciprocal interactions between the ductal epithelia and adjacent stroma. Alx4 is a
mesenchymally restricted homeodomain transcription factor expressed in a number of developing tissues, including skin appendages such as hair
follicles, whiskers and teeth. We show here that Alx4 is expressed in a subset of ERα-expressing mammary stromal cells adjacent to terminal end
buds and alveoli during puberty and pregnancy, respectively. Alx4 expression is induced in mammary stromal cells at the onset of puberty and can be
induced in prepubescent mice by administration of 17β-estradiol. In order to determine the role of Alx4 during mammary gland development, we
characterized mammary gland development of mice homozygous for the null allele of Alx4, lstD. Mammary glands from animals lacking Alx4
activity exhibit profound alterations in ductal morphogenesis. Overall development is delayed, ducts being grossly distorted in size and structure.
Terminal end buds are also disoriented, displaying aberrant architecture during bifurcation. Despite the developmental delay, the ductal network
typically reaches the limits of the fat pad. However, during puberty and in the adult virgin mice, the frequency and density of branch points is
significantly reduced. We show further that the defective ductal morphogenesis is due to defects in stromal cells. Specifically, when injected into the
cleared fat pad of wild-type recipients, mixed populations of wild-type epithelial cells and Alx4-deficient stromal cells give rise to retarded ductal
morphogenesis. Wild-type stromal cells mixed with Alx4-deficient epithelial cells result in normal progression of ductal development. Defective
branching morphogenesis in Alx4-deficient females is not due to a loss in expression of HGF, since the level of HGFmessage in mammary stromal
cells is similar in mutant and wild-type littermates. MMP3 is similarly expressed while a 40% increase in MMP2 and a 50% decrease in MMP9
message levels in Alx4-deficient mice relative to their wild-type littermates is observed. Thus, the activity of the stromally restricted homeodomain
factor, Alx4, is required for normal branching morphogenesis of the ductal epithelia during pubescent mammary gland development.
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The mammary gland is a specialized skin appendage which,
like tooth buds and hair follicles, develops under the influence
of inductive, reciprocal interactions between the embryonic
ectoderm and underlying mesenchyme (van Genderen et al.,
1994; Veltmaat et al., 2003). While the principle architectural
components of the mammary gland are established prior to
birth, significant postnatal development occurs for this tissue.
The rudimentary ductal tree of the mammary gland established
during embryogenesis is hormonally stimulated at puberty to⁎ Corresponding author. Fax: +1 416 978 5959.
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doi:10.1016/j.ydbio.2006.05.032expand into the fat pad (Silberstein, 2001; Silberstein et al.,
1994). Branching morphogenesis terminates at the end of
puberty by which time the ductal structures have reached the
limits of the fat pad. While undergoing limited estrous-
dependent cyclical changes in the adult virgin, a second phase
of postnatal development arises with the onset of pregnancy,
initially through side-branching morphogenesis followed by
the appearance of alveoli (Nandi, 1958; Richert et al., 2000;
Silberstein, 2001). The alveoli, which produce milk proteins
during lactation, then regress during involution through
programmed cell death, returning the mammary gland to a
similar, though phenotypically distinct state relative to the
mammary gland of the adult virgin (Richert et al., 2000;
Master et al., 2005).
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the mammary gland depends critically on the formation of a
unique structure at the ends of ducts known as the terminal end
bud (TEB) (Silberstein, 2001; Silberstein et al., 1994). The
TEB, which harbors mammary gland stem cells capable of
reconstituting the entire epithelial aspects of the mammary
gland, is characterized by multilayered body cells surrounded
by a single layer of caps cells. Body cells appear to give rise to
the luminal epithelial cells while cap cells are progenitors of
the myoepithelial cell layer. During puberty, branching
morphogenesis producing the ductal network of the mammary
gland occurs principally through bifurcation of the TEB.
Terminal end buds persist throughout puberty until the ducts
reach the limits of the fat pad. In the adult virgin, the ends of
the ducts retain a bilayered structure once the TEBs have
regressed (Richert et al., 2000).
Mammary epithelial morphogenesis depends on both instruc-
tive and permissive signals emanating from the supporting
mammary stroma (Wiseman and Werb, 2002). The stroma
includes fibroblasts, the extracellular matrix (ECM), adipocytes,
preadipocytes,bloodvessels,aswellas inflammatorycellssuchas
macrophages and eosinophils (Gouon-Evans et al., 2000; Pollard
and Hennighausen, 1994). The importance of stromal signals for
morphogenetic behavior of the epithelial compartment has been
demonstrated in a number of systems. So, for example, soluble
growth factors expressed from the fibroblasts surrounding the
epithelial ducts, including hepatocyte growth factor (HGF) and
insulin-like growth factor-1 (IGF-1), are responsible for both
morphogenic andmitogenic processes as well as for cell survival
in the adjacent epithelial compartments (Kleinberg et al., 2000;
Niranjan et al., 1995; Soriano et al., 1998; Walden et al., 1998;
Yang et al., 1995). Indeed, estrogen-dependent mammary
epithelial morphogenesis appears to be mediated, at least in part,
throughestrogen receptor alpha (ERα)-dependent transcriptional
activation of HGF (Zhang et al., 2002). The activation of stromal
Epidermal Growth Factor receptor (EGFR) in a paracrine
mechanism by ADAM17 mediated release of epithelial amphir-
egulin has also recently been shown to be required for mammary
epithelial development (Sternlicht et al., 2005). Additional cell
types, such as macrophages and eosinophils, are recruited to the
TEBs and are also required for normal branching morphogenesis
of the postnatal mammary gland. In animals deficient for these
myeloid cells, delayed and aberrant ductal maturation ensues,
resulting in defective TEB formation, impaired ductal branching
and disoriented penetration of the fat pad (Gouon-Evans et al.,
2000, 2002).
Aristaless-like 4 (Alx4) is a paired-like homeodomain factor
expressed in the mesenchymal compartment of a number of
specific developing tissues, including hair follicles, teeth,
craniofacial skeletal and skull precursors (Hudson et al., 1998;
Qu et al., 1997). Expression of Alx4 in the anterior aspect of the
developing limb bud confines the Sonic HedgeHog-expressing
cells of the Zone of Polarizing Activity (ZPA) to the posterior
aspect of this tissue (Chan et al., 1995; Qu et al., 1998). Mice
lacking Alx4 activity exhibit a duplication of the ZPA resulting
in preaxial polydactyly. Alx4-deficient mice also exhibit dorsal
alopecia, defective craniofacial structures, hemimelia (absenceof the tibia) and body wall closure defects. In humans, both
vascular and cortical abnormalities have been attributed to a
DNA-binding defective mutant of ALX4 in parietal foramina
type 2 (Mavrogiannis et al., 2001; Valente et al., 2004; Wu et al.,
2000;Wuyts et al., 2000).We demonstrated previously that Alx4
is expressed in a number of tissues whose development depends
on expression of the mediator of Wnt signaling, lymphoid
enhancer factor 1 (Lef1) (Hudson et al., 1998).Mice deficient for
Lef1 lack teeth, hair, whiskers and interestingly, embryonic
mammary glands also fail to develop in these mice (van
Genderen et al., 1994). Indeed, we demonstrated previously that
Alx4 and Lef1 form co-complexes, regulate the promoter
activity of at least one candidate gene (Boras and Hamel, 2002)
and, when simultaneously absent, result in early embryonic
lethality (9.0 dpc) due to defective vasculogenesis (Boras-
Granic et al., 2006).
Given the role of Alx4 activity in the mesenchymal
compartment of skin appendages whose development also
depends on Lef1 activity (Kratochwil et al., 1996; van Genderen
et al., 1994), we hypothesized that Alx4 activity would also play
a role in the development of the mammary gland. We demon-
strate here that Alx4 is expressed in a subset of stromal cells
adjacent to TEBs during puberty and alveoli during pregnancy.
We show further that in the absence of Alx4 activity specifically
in mammary stromal cells, impairment during puberty of
mammary epithelial ductal elongation and branching morpho-
genesis ensues.
Materials and methods
Mice and antibodies
Strong’s luxoid(lstD), an inbred strain of mice harboring a point mutation
(R206Q) in the homeodomain of Alx4, thereby inhibiting its DNA-binding
activity (Forsthoefel, 1962, 1963; Forsthoefel et al., 1966; Qu et al., 1998) was
obtained from Dr. R. Wisdom (St. Jude's Childrens Hospital) and backcrossed
onto the C57Bl/6 background (Charles River) for >12 generations. The anti-
Alx4 monoclonal antibody, KAb07, was developed in our lab, the rabbit anti-
ERα antibody (sc-542) was purchased from Santa Cruz and anti-BrdU antibody
(347580) from BD Pharmingen.
Immunohistochemistry, immunofluorescence and whole-mount
analysis
Paraffin-embedded tissue sections were deparaffinized in xylene and
rehydrated gradually through 100%, 95%, 70% ethanol and water. Antigen
retrieval was performed by boiling sections for 10 min in 10 mM sodium citrate
preheated in a microwave oven for 3 min before immersing slides. Immunohis-
tochemistry was performed according to the HRP-AEC system from R&D
(CTS003 and CTS006). Briefly, after the solution cooled, sections were blocked
for endogenous peroxidase activity with 3% H2O2 for 15 min. Sections were
further blocked in serum for 1 h, avidin and biotin blocking reagents and the
primary antibody of interest diluted in PBS was incubated on slides at 4°C
overnight. Samples were washed and incubated with biotinylated secondary
antibody for 1 h. Following washes, streptavidin conjugated to HRP was
incubated on slides for 30 min. Sections were incubated with AEC chromogen in
the supplied buffer and staining stopped by a further washing step. For
immunofluorescence, sections were permeabilized with Triton X-100 in PBS for
5 min following antigen retrieval. Sections were blocked with 5% serum in PBS
with saponin (10 μl/ml) for 1 h. Primary antibody was applied for 1 h, washed in
PBS and a fluorescently labeled secondary antibody added to samples for 45 min.
Whole-mount analysis of mammary glands was performed as previously
described (Rasmussen et al., 2000).
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17β-Estradiol (Sigma), prepared from 1 mg/ml stock solution in ethanol,
was administered subcutaneously at 0.1 mg in 0.1 ml corn oil per 10 g mouse.
Prepubescent mice at 2 weeks of age were primed with an injection of 17β-
estradiol on day 1, followed by a second injection on day 2 and sacrificed by
cervical dislocation 24 or 48 h postpriming. Controls were left untreated or
treated with corn oil alone. BrdU (BD Pharmingen) was injected intraper-
itoneally into mice (50 mg/kg in PBS) 2 h prior to sacrifice.
Isolation of primary mouse mammary fibroblasts
Primary mammary fibroblasts were isolated from pubescent mouse mammary
glands as described previously (Niranjan et al., 1995). In brief, dissected
mammary glands were minced and homogenized in 4 ml/g of a digestion cocktail
of Ham's F12 media containing 3 mg/ml Collagenase A (Boerhinger Mannheim
#103586) followed by an incubation for 1 h at 37°C in a shaker. Contents were
then centrifuged for 1 min at 150 rpm, and the supernatant containing loosely
associated fibroblast cells was decanted into another tube and centrifuged further
at 1500 rpm for 10 min. The pellet was washed in DMEM + 10% FBS,
centrifuged, resuspended in Ham's F12 plus 10% FBS:DMEM plus 10% FBS
(1:1) and supplemented with transferrin, insulin, EGF, gentamycin and plated.
The pellet containing epithelial cells and tightly associated fibroblasts from the
first digestion cocktail was subjected to another round of digestion for 30 min at
37°C. The cocktail was centrifuged for 5 min at 1500 rpm, the pellet washed and
plated after resuspension in the media described above. After the tightly
associated fibroblast cells settled, the media containing epithelial organoids were
removed and fibroblast cells replenished with fresh media.
Detection of message for Alx4, HGF and IGF-1 was performed using
Superscript One-Step RT-PCR kit (Invitrogen) according to the manufacturer's
instructions. Primers for PCR were as follows: IGF-1: Forward: 5′-GCTCTTC
AGTTCGTGTGTGG-3′, Reverse: 5′-TTGGGCATGTCAGTGTGG-3′; HGF:
Forward: 5′-TTGGCCATGAATTTGACCTC-3′ Reverse: 5′-ACATCAGTCT-
CATTCACAGC-3′; Alx4: Forward: 5′-CAAAGGCAAGAAGCGGCG-
GAATC-3′, Reverse: 5′-GGTACATTGAGTTGTGCTGTCC-3′.
Transplantation experiments and quantitative PCR
Fractions of purified mammary epithelial cells and stromal cells from wild-
type and Alx4lstD/lstD mice were isolated as described above and previously (for
review, see Ip and Darcy, 1996). Epithelial cells from wild-type mice and
stromal cells from Alx4lstD/lstDmice as well as the reciprocal recombination were
then injected into the cleared fat pad of anesthetized prepubescent (3 weeks)
C57Bl/6 female recipients. In each case, the reciprocal recombinations (wild-
type epithelia/Alx4lstD/lstD stroma and Alx4lstD/lstD epithelia/wild-type stroma)
were injected into contralateral #4 mammary glands of the same recipient.
Recipients were allowed to recover and reconstituted mammary glands
harvested for whole-mount analysis 5 weeks postimplantation.
For quantitative RT-PCR, RNA from purified fractions of epithelial and
stromal cells from wild-type and Alx4lstD/lstD mice was isolated as described
above. Eight nanograms were used for each Q-PCR reaction. Each sample was
performed in triplicate, standardized against genomic DNA and corrected for dif-
ferences usingβ-actin as a control. Primers pairs were as follows: HGF: Forward:
5′ aggttacaggggaaccagca 3′, Reverse: 5′ gcttgtgagggtactgcgaatcc 3′; MMP2:
Forward: 5′-tgcgggttctctgcgtcctgtg 3′, Reverse: 5′-acttgatgatgggcgatggtgc 3′;
MMP3: Forward: 5′-tgaagggtcttccggtcctg-3′, Reverse: 5′-ccttgcactgtcatgcaat-
gggt-3′; MMP9: Forward: 5′-tgaacaaggtggaccatgaggtg 3′, Reverse: 5′-tcaaggg-
cactgcaggaggtcg 3′.
Results
Stromal-specific expression of Alx4 during postnatal mammary
gland development
We determined previously that Alx4 transcript is expressed
in stromal cells adjacent to TEBs in pubescent female mice(Hudson et al., 1998). As Fig. 1 depicts, Alx4 expression is
altered during distinct phases of postnatal mammary gland
development. Specifically, Alx4 is expressed rarely in stromal
cells surrounding the primitive ductal structure prior to puberty
(Figs. 1A–B). As mice enter puberty, the appearance of TEBs
coincides with an expansion of cells expressing Alx4 (Figs.
1C–D). Alx4-expressing cells are observed in the stroma
directly adjacent to the TEB, an apparent concentration of
these cells present along the flanks of the TEB where it
narrows to form luminal and myoepithelial cell layers of the
subtending duct. However, not all of the cells adjacent to the
TEB express Alx4. In contrast to the TEB, a small proportion
of stromal cells adjacent to the ductal structures express Alx4
(arrowhead, Fig. 1E). By the end of puberty and in the adult
virgin (Figs. 1F–G), Alx4 expression is generally reduced
although it can still be detected in stromal cells associated with
the end of ducts and occasionally adjacent to the ducts
(arrowheads, Fig. 1H). Strong expression of Alx4 protein is
also apparent during pregnancy where many Alx4-expressing
cells are observed associated with alveoli (Figs. 1I–J).
Fig. 2 illustrates that Alx4-expressing stromal cells also
express estrogen receptor-alpha (ERα). Specifically, while ERα
is highly expressed in the mammary luminal epithelial cells, its
expression is also observed in the adjacent stromal cells
coincident with cells which express Alx4. We isolated loose
stromal cells as well as stromal cells tightly associated with the
epithelial component of the pubescent mammary gland.
Immunofluorescence confirms the presence of Alx4 protein in
the nuclei of most fibroblasts 48 h postplating (Fig. 3A). Alx4
expression is also detected by RT-PCR in cells plated for 4 h and
3 days in tissue culture (Fig. 3B). Furthermore, this fraction of
stromal fibroblasts expresses HGF and IGF-1 (Fig. 3C), as has
been reported previously (Kamalati et al., 1999; Kleinberg et al.,
2000; Niranjan et al., 1995; Ruan and Kleinberg, 1999).
Hormonal regulation of Alx4 expression
We determined next that Alx4 expression could be induced
following administration of 17β-estradiol in prepubescent
mice. Specifically, corn oil alone or corn oil with 17β-
estradiol was injected subcutaneously into 2-week-old, prepu-
bescent mice. Two hours prior to harvesting the mammary
glands, animals were also injected with BrdU in order to
determine the proportion of cells in S phase. As Fig. 4
illustrates, induction of Alx4 expression in stromal cells is
evident in mammary glands in prepubescent mice 48
h postpriming with 17β-estradiol (Fig. 4C). Untreated animals
(Fig. 4A) or animals injected with corn oil alone (Fig. 4B) did
not express Alx4. Fig. 4G shows further that an increased
number of stromal, and epithelial cells were proliferating under
the influence of 17β-estradiol as evidenced by the increase in
BrdU containing cells relative to the control animals (Figs.
4E–F). The induction of Alx4 is not synchronous with 17β-
estradiol-dependent induction of cell cycle progression,
however. Twenty-four hours after 17β-estradiol administration,
an increase in BrdU-positive cells (Fig. 4H), but not Alx4-
expressing cells (Fig. 4D), is observed.
Fig. 1. Alx4 is expressed during postnatal mammary gland development. Whole-mount analysis of mammary glands in prepubescent (A), pubescent (C), adult
virgin (F) and day 9 pregnant mice (I). Immunohistoichemical detection of Alx4 expression in prepubescent (B), pubescent (D–E), adult virgin (G–H) and day 9
pregnant mice (J). Arrows in panels E and H denote Alx4 expressing cells. Scale bars in A–200 μm; scale bars in panels C, F and I–1000 μm; scale bars in
panels B, D, E, G, H and J–15 μm.
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of Alx4lst
D/lst D mice
Normal mammary gland development during puberty
requires signaling between TEBs, which give rise to the luminal
and myoepithelial cells, and the adjacent stromal cells. We
hypothesized that loss of Alx4 activity would impair signaling
from Alx4-expressing stromal cells to the epithelial compart-Fig. 2. Colocalization of Alx4 and ERα expression in mammary gland stromal cells
colocalizes with stromal cells expressing ERα (B). Overlapping expression seen inment, resulting in defective ductal morphogenesis. In order to
test this hypothesis, we employed mice lacking functional Alx4.
Strong’s luxoid (lstD) is an inbred strain of mice harboring a
point mutation (R206Q) in the DNA-binding homeodomain of
Alx4, rendering the protein inactive (Qu et al., 1998). Mice
homozygous for the lstD allele (Alx4lstD/lstD) phenocopy mice
with a complete deletion of Alx4 (Qu et al., 1998). We
backcrossed the lstD mutation onto C57Bl/6 (>12 generations). Immunofluorescent labeling reveals Alx4 expression (A) in mammary stroma
merged image (C). Scale bar in A–15 μm.
Fig. 3. Detection of Alx4 in primary fibroblast populations isolated from the
pubescent mouse mammary gland. (A) Immunofluorescent detection of Alx4
protein in the nuclei of primary mammary fibroblast cells 48 h after plating in
tissue culture dishes. (B) Confirmation by RT-PCR of expression of the Alx4
transcript in isolated stromal cells 4 h and 3 days after plating stromal
fibroblasts. (C) RT-PCR on fraction of isolated fibroblasts expressing Alx4 also
express message for HGF and IGF. Scale bars in panel A–20 μm.
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mammary gland development.
Lack of Alx4 activity results in profound impairment in
ductal morphogenesis. By whole-mount analysis, several
striking features are evident in the developing ductal epithelia
in Alx4lstD/lstD animals during puberty (Fig. 5). Progression of
ductal invasion into the fat pad during puberty is greatly delayed
in the animals lacking Alx4 (Fig. 5Aversus B). It is also evident
that aberrant morphogenesis arises at this stage. Specifically,
ducts between the nipple region and the lymph node are very
large in diameter, often appearing disoriented and having highly
distorted and variable shapes. For example, ducts displayFig. 4. 17β-Estradiol-induced expression of Alx4 in the prepubescent mammary glan
were untreated (A), treated with corn oil for 48 h (B), treated with corn oil plus 17β-es
Detection of BrdU incorporation in the same mammary glands as panels A–D. Arrosudden alterations in diameter (Fig. 5E, arrow) where an
unusually large duct will give rise to a smaller, distal structure.
Bifurcation of the terminal end buds is also often impaired with
the angle of bifurcation considerably reduced relative to wild-
type TEBs (compare Figs. 5C–D with F and I, double arrow
head). Indeed, TEB are occasionally observed to overlap (Figs.
5I and F, double arrow head) rather than extend away from each
other (Figs. 5C–D, double arrow head). The TEB themselves
are typically misshaped, the region containing body cells often
extending backwards from the TEB (Fig. 5H, solid arrow
heads). Interestingly, ducts often appear to have nodes of cells in
their lumens (Figs. 5F and J, single arrows), a structure not seen
in wild-type ducts.
We also examined the structure of the mammary glands of
adult virgin Alx4lstD/lstD animals (Fig. 6). The ductal network in
the mammary glands of Alx4lstD/lstD females typically reach the
limits of the fat pad. It is evident, however, that the defects
observed in the pubescent mice persist in adult virgin animals.
So, for example, ducts proximal to the nipple region are
distorted, exhibiting twisted and kinked shapes and overall being
considerably larger in diameter (compare Figs. 6E and C).
In order to confirm that branching morphogenesis was
impaired, we quantified the number of branch points in pube-
scent and adult animals. As Fig. 7 reveals, a significant reduction
in total number of branches in mammary glands of Alx4lstD/lstD
mice versus wild-type litter mates, respectively, is observed in
both pubescent (45.33 ± 14.77 versus 164 ± 17.93; P = 0.0342)
and in adult virgin (78.33 ± 8.01 versus 230.67 ± 39.60;
P = 0.0413) animals. The reduction of branch points during
puberty is reflected in the significant reduction in TEBs
(7.67 ± 1.76 versus 21.33 ± 1.2; P = 0.0111) in Alx4lstD/lstD
mice compared to wild-type mammary glands, respectively.
When corrected for differences in the size of the adult mammary
glands, differences in the density of branching is also evident.
Thus, during puberty (45.33 ±14.77 versus 95.67 ± 14.84,
P = 0.0016) and in adult virgins (78.33 ± 8.01 versusd. (A–D) Alx4 expression in prepubescent mammary glands from animals that
tradiol for 48 h (C) or treated with corn oil plus 17β-estradiol for 24 h (D). (E–H)
ws in panels B and C–Alx4-expressing cells. Scale bars in panelsA–H–15μm.
Fig. 5. Impairment of ductal morphogenesis during puberty in Alx4lstD/lstD mice. Whole-mount analysis of wild-type (A, C, D) and Alx4lstD/lstD (B, E–J) mammary
glands. Invasion of the fat pad during puberty is delayed inAlx4lstD/lstDmutantmammary glands. TEBs often bifurcate at very close angles inAlx4lstD/lstDmice compared
to the significant spacing seen in wild-type TEBs (compare double arrows heads in panels I and F versus C and D, respectively). Lumens of ducts in Alx4lstD/lstD
mammary glands frequently exhibit nodes of cells (closed arrows in panels F and J). Body cells in TEBs in Alx4lstD/lstD mammary glands often extend back towards
the subtending ducts (arrowheads in panelH). Radical changes in the size of ducts at bifurcations are also seen inAlx4lstD/lstDmicewhere large, distorted ducts give rise to
a duct with very small diameter (open arrows in panels E and G). Scale bars in panels A–B 1000 μm; scale bars in panels C, E, G and I–250 μm; scale bars in panel
D–125 μm; scale bars in panels F, H and J–100 μm.
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Alx4lstD/lstD mice versus wild-type littermates, respectively, is
significantly reduced.
Impairment of branching morphogenesis is due to defects in
stromal cells
In order to discount the possibility that the observed
alterations were due to systemic effects in Alx4lstD/lstD mice
and to prove that they arose due to defects in the stromal
compartment, we performed transplantation experiments using
recombined fractions of stromal and epithelial cells. Specifically,
separate populations of stromal cells and epithelial cells were
isolated from 6-week-old Alx4lstD/lstD mice and wild-type
littermates. Stromal cells from Alx4lstD/lstD mice were then
mixed with wild-type epithelial cells and vice versa and these
reciprocally recombined populations injected into the cleared fat
pads of prepubescent wild-type recipients. As Fig. 8 demon-
strates, retarded ductal morphogenesis is seen five weeks aftertransplantation in the mammary glands of recipients receiving
wild-type epithelial cells but stromal cells from Alx4lstD/lstD
mice. In contrast, development of mammary glands of recipients
receiving wild-type stromal cells but epithelial cells from Alx4-
deficient mice progressed normally. Thus, these data reveal that
impaired ductal morphogenesis in Alx4lstD/lstD mice arises
specifically due to loss of Alx4 activity in mammary stromal
cells.
Despite alterations in the gross morphology of the mammary
glands in Alx4-deficient mice, consistent differences in the fine
structure of ducts and surrounding stroma are not observed
(Fig. 9). For example, mutant Alx4 protein is expressed in
Alx4lstD/lstD mice. Fig. 9B illustrates that the cells which express
mutant Alx4 are present in the region surrounding the terminal
end buds, similar to Alx4-expressing cells in wild-type
littermates (Fig. 9A). Likewise, expression of p63 in myoe-
pithelial cells and in the cap cell layer of TEBs in Alx4-deficient
animals is indistinguishable from wild-type littermates
(Figs. 9E–F). Picro-sirius red staining for extracellular matrix
Fig. 6. Defective ductal morphogenesis in adult virgin Alx4lstD/lstD animals. Whole-mount analysis of wild-type (A, C and D) and Alx4lstD/lstD (B, E, F) mammary
glands. In adult virgin Alx4lstD/lstD mammary glands, ductal growth has reached the limits of the fat pad (B) as observed in wild types (A). However, ducts in
Alx4lstD/lstD animals retain many aspects of abnormal morphology found in pubescent mutants. Ducts proximal to the nipple region in Alx4lstD/lstD animals are distorted
and much larger (E) than those in comparable locations in wild types (C), while ducts distal to the nipple are much thinner (F) than wild-type ducts (D).
Fig. 7. Defective branching in Alx4lstD/lstD mammary glands. Branch points in
mammary glands from Alx4lstD/lstD and wild-type littermates were quantified
from whole-mount preparations of mammary gland #4. The total number of
branch points during puberty and in adult virgins was significantly reduced in
Alx4lstD/lstD compared to wild-type littermates. When corrected for differences in
the size of the mammary glands, a significant reduction in the density of branches
in Alx4lstD/lstD females was apparent at both stages. Comparison of the number of
TEBs during puberty also showed a significant reduction in Alx4lstD/lstD females
relative to wild-type littermates.
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wild-type animals (Figs. 9C–D). Normal expression patterns for
laminin, keratin 5, keratin 14, smooth muscle actin, E-cadherin
and β-catenin are also observed in Alx4lstD/lstD mammary
glands (see Supplementary data). Furthermore, the apparent rate
of proliferation in terminal end buds, as determined by BrdU
incorporation, is similar between Alx4lstD/lstD and wild-type
littermates (Figs. 9G–H).
Targets for Alx4-dependent transcription are not known.
However, a number of factors expressed in the stromal
compartment of the mammary gland are known to be required
for normal morphogenesis of the mammary gland during
puberty, such as HGF (Woodward et al., 1998; Zhang et al.,
2002) and matrix metalloproteinases (Wiseman et al., 2003).
Thus, we quantified the levels of expression of factors expressed
in stromal cells of 5-week-old wild-type and Alx4lstD/lstD
pubescent littermates. As illustrated in Fig. 10, when normalized
against the β-actin control, no significant differences in the
levels of HGF or MMP3 message were evident in stromal cells
isolated from wild type compared to Alx4lstD/lstD littermates. In
contrast, we observed a 40% increase in MMP2 and 50%
reduction in MMP9 mRNA expression. Thus, the defects
associated with the loss of Alx4 activity in the pubescent
mammary gland are associated with altered expression of two
factors known to play a role in mammary gland development.
Fig. 8. Altered branching morphogenesis in Alx4lstD/lstD mammary glands is due to defects in stromal cells. Mammary epithelial cells and stromal cells were
individually isolated from 5-week-old wild-type and Alx4lstD/lstD females. Mutant stromal cells and wild-type epithelia as well as wild-type stroma and mutant epithelia
were recombined and transplanted into contralateral cleared fat pads of wild-type pubescent recipients. Mammary glands from recipients were harvested 5 weeks later
and whole mounts of mammary glands reconstituted with Alx4lstD/lstD epithelia plus wild-type stroma (top panel) or wild-type epithelia plus Alx4lstD/lstD stroma
(bottom panel) prepared for analysis.
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the murine mammary gland which express the homeodomain
factor Alx4. Significantly, in the absence of Alx4 activity in
these stromal cells, mammary epithelial ductal morphogenesis
is impaired giving rise to aberrant ductal structures and a
reduction in the number of branches in the principal ductal
network.
Discussion
Branching morphogenesis of the postnatal mammary gland
requires continuous reciprocal signaling between the growing
epithelia and its surrounding stromal microenvironment (Parmar
and Cunha, 2004; Robinson et al., 1999; Silberstein, 2001;
Wiseman and Werb, 2002). In this study, we identified a subset
of stromal cells associated primarily with the TEBwhich express
the homeodomain factor, Alx4.We showed previously that Alx4
is expressed in the mesenchymal aspect of another skin
appendage, the hair follicle, during both embryonic and
postnatal development (Hudson et al., 1998 and P. Joshi,
unpublished observation). In the case of the mammary gland,
Alx4 expression is not observed during embryonic mammary
gland development (data not shown) or during quiescent stages
of postnatal mammary gland development. However, induction
of Alx4 expression is observed as the mammary ductal structurespenetrate the fat pad during puberty and during alveolar
formation at pregnancy. Consistent with the appearance of its
expression during ovarian hormone-dependent stages of mam-
mary gland morphogenesis, Alx4 expression increases follow-
ing administration of 17β-estradiol in prepubescent females. We
showed further a role for Alx4 in mammary gland development
where, in its absence, impairment of ductal and branching
morphogenesis arises. This effect is due to loss of Alx4 activity
specifically in the stromal compartment since transplantation of
wild-type epithelia and Alx4-deficient stromal cells into the
cleared fat pad of a wild-type recipient resulted in impaired
ductal morphogenesis. Thus, we have identified a homeodomain
factor defining a subset of stromal cells adjacent to TEBs
important for normal mammary epithelial morphogenesis.
The principal hormone regulating ductal growth during
puberty is estrogen secreted by the ovaries. One mediator of
estrogen signaling, ERα, is expressed in both epithelial and
stromal cells of the mouse mammary gland (Fendrick et al.,
1998; Silberstein et al., 1994). While ERα is expressed in both
mammary stromal cells as well as in epithelial cells, recent
evidence revealed that expression of ERα in mammary
epithelial cells, but not in mammary stromal cells, was required
for morphogenesis during puberty (Mallepell et al., 2006).
Previous studies indicated that ERα may mediate some of its
morphogenic effects through transcriptional control of HGF
Fig. 9. Alx4lstD/lstD mammary glands are similar to wild types at the histological level. Expression of the Alx4 functionally null protein is detected in stromal cells
surrounding TEBs in Alx4lstD/lstD mammary glands (B), comparable to the expression pattern along wild-type TEBs (A). Picro-sirius red staining of collagen and the
basement membrane did not reveal any defects in the ECM of Alx4lstD/lstD mammary glands (D) compared to the wild type (C). Organization of cells in TEBs was
intact in Alx4lstD/lstD animals as evidenced by p63 staining for the cap cell layer (compare F with E). Cell proliferation was mostly localized to the cap cell layer in
Alx4lstD/lstD TEBs (H) and was similar to the wild type (G). Scale bars in panels A–B–15 μm; scale bars in panels C–D–50 μm; scale bars in panels E–H–25 μm.
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suggesting that ERα activity in the stromal compartment
plays a role in normal mammary gland development. Given the
induction of Alx4 at the onset of puberty and in prepubescent
mice following administration of 17-β-estradiol, we predict that
Alx4 may mediate, at least in part, some of these estrogen-
dependent effect during mammary gland morphogenesis at
puberty.
The mechanisms determining TEB bifurcation is not well
understood (for example see (Silberstein, 2001). We observed
that at all stages of postnatal mammary gland development, the
relative number of branch points in animals lacking Alx4 was
significantly reduced. This reduction was also observed for adult
virgin Alx4lstD/lstD mice where, despite reaching the limits of thefat pad, the absolute and relative number of branch points
remained reduced compared to the wild type. Failure to restore
the relative number of branch points in adult Alx4lstD/lstD mice is
similar toCsfmopmice (Gouon-Evans et al., 2000). In these latter
animals, loss of macrophage-colony stimulating factor-1 (CSF1)
expression from epithelial cells results in a failure to recruit
macrophages to the TEB during puberty. Like Alx4-deficient
animals,Csfmopmice exhibit retarded ductal morphogenesis and
a decrease in the number of branches. Defective ductal
morphogenesis in Csfmop and Alx4lstD/lstD mice have a number
of additional overlapping characteristics. Significantly, as was
described for Csfmop mice and as we showed for Alx4lstD/lstD
mice, terminal end buds are often disoriented. This disorienta-
tion presumably gives rise to aberrant ductal elongation, ducts
Fig. 10. Altered expression of factors in mammary stromal cells from Alx4lstD/lstDmice. Expression levels of HGF, MMP2, MMP3 and MMP9 in stromal cells isolated
from wildtype (WT) and Alx4lstD/lstD (lstD) mice were determined by quantitative RT-PCR (qPCR). No differences in the levels of HGF and MMP3 were observed
between pairs of WT and lstD mice. In contrast, MMP2 was expressed at levels 40% higher and MMP9 at levels 50% lower in stromal cells from lstD mice relative to
their WT littermates.
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we observe in Alx4lstD/lstD mammary glands, that the architec-
ture of bifurcation is significantly impaired. UnlikeCsfmopmice,
however, the defects observed in Alx4-deficient animals do not
appear to be the result of impaired recruitment of eosinophils or
macrophages; both of these cells types are detected in the stroma
associated with TEBs in pubescent Alx4-deficient mice (data not
shown).
The transplantation studies confirmed that the defects in
Alx4lstD/lstD mice were due specifically to stromal cells and was
not a cell-autonomous effect of epithelial cells. Given that
stromal cells expressing inactive Alx4 were detected around the
TEBs of pubescent Alx4lstD/lstD mice, we propose that the
phenotype of the mammary gland in these animals arises due to
the loss of expression of factors under the transcriptional control
of Alx4. While no endogenous transcriptional targets of Alx4
have been characterized, we detected altered expression of two
factors, MMP2 and MMP9, known to participate in the
mammary gland morphogenesis during puberty (Wiseman
et al., 2003). Alterations in this class of proteins may be
consistent with the fact that Alx4lstD/lstD mice exhibit altered
gross morphology and impaired branching morphogenesis
rather than an apparent loss of some particular cell type. Thus,
changes in the expression of factors which are required for the
mechanical penetration of the TEB into the fat pad might be
expected, as we showed for some of the MMPs, rather than
changes in factors which control morphogenesis, as was the case
for HGF. Indeed, given the lack of differences in the level of
expression of HGF in stromal cells from Alx4lstD/lstD versus
wild-type littermates, we predict that estrogen-induced activa-
tion of Alx4 expression may be required for control of signaling
pathways distinct from HGF but which may mediate HGF-
dependent branching morphogenesis. Microarray analysis is
currently being used to identify altered gene expression in a
global systematic manner.
To conclude, these data demonstrate that the homeodomain
factor, Alx4, is expressed in a subset of stromal cells in themammary gland. Furthermore, in the absence of this estrogen-
inducible protein, mammary epithelial morphogenesis is
impaired.
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